Articles From: API Technologies Launches New Configurable Frequency Synthesizers to Alere Inc. Announces Second Quarter 2014 Results


Feature-rich platform expands company's footprint in communications, industrial, and defense applications ORLANDO, Fla.
Sign-up for API Technologies Launches New Configurable Frequency Synthesizers investment picks
Ares Commercial Real Estate Corporation (NYSE:ACRE) announced today that its wholly owned qualified REIT subsidiary ACRE Commercial Mortgage 2014-FL2 Ltd.
Sign-up for Ares Commercial Real Estate Corporation Announces Securitization investment picks
SHREWSBURY, N.J., Aug.
Sign-up for InterCloud Secures New Professional Services Project investment picks
2014/8/4
General Moly, Inc. (the "Company" or “General Moly”) (NYSE MKT and TSX: GMO), a U.S.-based molybdenum mineral development, exploration, and mining company, announced its unaudited financial results for the second quarter ended June 30, 2014.
Sign-up for General Moly Announces Second Quarter 2014 Results investment picks
2014/8/4
New Assessment and Deployment Services Enable Channel Partners to More Effectively Sell and Support EMC VNX and Unified Communications and Collaboration Solutions SANTA ANA, Calif.
Sign-up for Ingram Micro's New Expert Services Expand Channel Partners' Capabilties to Sell and Deploy Advanced Solutions investment picks
2014/8/4
LeapSearch, powered by KidZui technology, provides kid-safe browsing experience on market leading LeapFrog LeapPad tablets EMERYVILLE, Calif.
Sign-up for LeapFrog Acquires Kid-Safe Internet Browser, KidZui investment picks
Violin Memory®, Inc. , (NYSE:VMEM), a leading provider of all-flash storage arrays and appliances delivering application solutions for the enterprise, today announced that it will report financial results for its second fiscal quarter ended July 31, 2014 on Wednesday, August 27, 2014.
Sign-up for Violin Memory to Announce Second Fiscal Quarter 2015 Financial Results investment picks
MINNEAPOLIS, Aug.
Sign-up for SPS Commerce to Present at Upcoming Financial Conferences investment picks
JERSEY, Channel Islands, Aug.
Sign-up for Quotient Appoints Sarah O'Connor to Board of Directors investment picks
Pfizer Inc. (NYSE:PFE) announced today that the members of Rascal Flatts, the most-awarded country music band of the past decade, are among the thousands of people who choose Nexium ® 24HR every day since becoming available without a prescription for frequent heartburn this past May.
Sign-up for Rascal Flatts Joins the Thousands of People Who Choose Nexium® 24HR Every Day for Their Frequent Heartburn investment picks
Sensient Technologies Corporation (NYSE: SXT) today announced that Dick Hobbs will retire from his role as Senior Vice President and Chief Financial Officer in February 2015 and that he will be succeeded by Stephen Rolfs, Sensient’s current Senior Vice President, Administration.
Sign-up for Sensient Technologies Corporation Announces CFO Transition investment picks
Perion Network Ltd.
Sign-up for Perion to Present at Upcoming Investor Conferences in Boston investment picks
Lannett Company, Inc. (NYSE: LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Oxycodone Hydrochloride Capsules, 5 mg, the therapeutic equivalent to the reference listed drug, Oxycodone Hydrochloride Capsules, 5 mg, of Lehigh Valley Technologies, Inc. According to IMS, for the year ended June 2014 total sales of Oxycodone Hydrochloride Capsules, 5 mg, at Average Wholesale Price (AWP) were approximately $7.1 million.
Sign-up for Lannett Receives FDA Approval for Oxycodone Hydrochloride Capsules 5 mg investment picks
NEW YORK (MarketWatch) -- Amgen Inc. shares (AMGN) climbed 3.5% in premarket trade Monday, after the company said a late-stage trial of a treatment for patients with relapsed multiple myeloma had positive results.
Sign-up for Amgen reports positive trial of multiple myeloma treatment investment picks
HOUSTON , Aug.
Sign-up for CARBO to Present at EnerCom's The Oil & Gas Conference® 19 investment picks
2014/8/4
By Barbara Kollmeyer, MarketWatch UBS strategists: Now isn't the time to bail out of stocks -Barbara Kollmeyer; 415-439-6400; AskNewswires@dowjones.com MADRID (MarketWatch) -- U.S. stock futures indicated a firmer start for Wall Street on Monday, as investors looked to claw back some territory after the worst weekly finish for the S&P 500 in two years.
Sign-up for UPDATE: U.S. stocks: Futures up as investors look to claw back ground investment picks
2014/8/4
NEW YORK (MarketWatch) -- AutoNation Inc. (AN) said it sold 27,484 new vehicles in July, up 8% from the same time a year ago.
Sign-up for AutoNation July retail sales climb 8% to 27,484 vehicles investment picks
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- HSBC PLC shares rose Monday following the banking heavyweight's financial results, helping to lift the benchmark FTSE 100 index.
Sign-up for UPDATE: HSBC shares lead climb in U.K. stocks investment picks
http://media.marketwire.com/attachments/201202/20972_BSFTlogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135070&ProfileId=051205&sourceType=1 GAITHERSBURG, MD --
Sign-up for BroadSoft Reports Second Quarter 2014 Financial Results investment picks
Levi & Korsinsky is investigating the Board of Directors of Bally Technologies, Inc. (“Bally Technologies” or “the Company”) (NYSE:BYI) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Scientific Games Corporation.
Sign-up for INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Bally Technologies, Inc. and Its Board of Directors In Connection With the Sale of the Company to Scientific Games Corporation investment picks
Kyprolis Helped Patients Live 8.7 Months Longer Without Their Disease Worsening Results to Form Basis of Regulatory Filings Beginning in 1H 2015 THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Phase 3 ASPIRE Trial Of Kyprolis® In Patients With Relapsed Multiple Myeloma Met Primary Endpoint investment picks
2014/8/4
- Interest rate volume rose 25 percent - Eurodollar futures volume increased 40 percent and Eurodollar options volume increased 38 percent - Open interest surpassed 100 million contracts and is up 20 percent year-to-date in 2014 CHICAGO , Aug.
Sign-up for CME Group Volume Averaged 12.2 Million Contracts per Day in July 2014, Up 13 Percent from July 2013 investment picks
CGI's proprietary genomic test has been CLIA and NYS licensed to stratify CLL and SLL patient into three distinct outcome groups: favorable, intermediate, and unfavorable It is the only comprehensive test to report on 20 clinically-validated and disease-relevant genomic regions focused on CLL and SLL The proprietary genomic test addresses a growing market of over 120,000 patients for the most common form of leukemia (CLL/SLL) RUTHERFORD, N.J., Aug.
Sign-up for Cancer Genetics, Inc. Releases the Only Comprehensive Genomic Test to Diagnose & Stratify the Most Common Form of Leukemia (CLL) investment picks
BRENTWOOD, Tenn., Aug.
Sign-up for Diversicare Announces the Acquisition of Operations of Two Facilities in Ohio investment picks
WALTHAM, Mass.
Sign-up for Alere Inc. Announces Second Quarter 2014 Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: API Technologies Launches New Configurable Frequency Synthesizers to Alere Inc. Announces Second Quarter 2014 Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices